Alerts will be sent to your verified email
Verify Email
SPARC
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
SPARC is a clinical stage bio-pharmaceutical company specializing in pharmaceutical research and development to create innovative therapeutics and drug delivery systems for enhancing patient care globally.
Sun Pharma Adv. Res major competitors are Dishman Carbogen Amc, Zenotech Laboratorie, Vivo Bio Tech, Jeevan Scientific, Syngene Internation., Suven Life Sciences, Hikal.
Market Cap of Sun Pharma Adv. Res is ₹4,610 Crs.
While the median market cap of its peers are ₹3,160 Crs.
Sun Pharma Adv. Res seems to be less financially stable compared to its competitors.
Altman Z score of Sun Pharma Adv. Res is -0.4 and is ranked 8 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jun | Dec | Sep | |||||||||||||||
| Investor Presentation | Sep | Jan Sep Nov Dec | Sep Oct | Sep Dec | Jun | Jun Sep | Jun | Jun | Jun | Dec | Mar | Jun Sep Dec | ||||||
| Conference Call | Mar | Mar Jun Sep Dec | Jun Sep Dec | Sep | Sep | Sep | Jun | Jun | Jun | Mar Dec | Jun | |||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
